The largest database of trusted experimental protocols

6 protocols using dexamethazone

1

Adipocyte Differentiation from Pre-adipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pre-adipocyte differentiation into mature adipocytes was achieved by exposing pre-adipocytes to an appropriate adipogenic hormone cocktail (dexamethazone, 3-isobutyl-1-methylxanthine, and insulin), according to a standard differentiation protocol as described elsewhere [38 (link)] In brief, two days past 70% confluency (day 0), cells were treated with 0.5 mM 3-isobutyl-1-methylxanthine (Sigma, Germany), 1.0 μΜ dexamethazone (Sigma, Steinheim, Germany), and 10 ng/mL of insulin, as final concentrations in DMEM. Two days later (day 2), the cells were cultured in maintenance medium, treated only with insulin (main adipogenic factor) and the medium was serially changed every two days, whereas lipid formation was monitored on a daily basis. All experiments were performed on the 8th day of the differentiation process.
+ Open protocol
+ Expand
2

Intestinal Organoid Culture Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recombinant proteins and neutralizing antibodies for mouse TNF and IL-6 were obtained from R&D Systems. Defined fetal bovine serum (FBS) was purchased from HyClone, vitronectin was from Thermo Fisher Scientific, and insulin, dexamethazone and a protease inhibitor cocktail were from Sigma. 3-Isobutyl-1-methylxanthine (IBMX) and pioglitazone were obtained from Wako. CAPE and Galiellalactone were from Tocris and Cayman Chemical, respectively. Antibodies for villin1 (ab3304), mucin 2 (Muc2) (ab11197 for human, ab76774 for mouse), and chromogranin A (ChgA) (ab15160) were purchased from Abcam. Anti-E-cadherin antibody (3195) was from Cell Signaling, anti-lysozyme antibody (A0099) was from Dako, and anti-perilipin1 antibody (GP29) was from Progen. Secondary antibodies for immunostaining were from Jackson ImmunoResearch.
+ Open protocol
+ Expand
3

Isolation and Differentiation of Adipocyte and Fibroblast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preparation of the SVF from WAT was performed as previously described (8 (link)). In brief, WAT was minced with scissors and digested with 2 mg/mL Collagenase I (Sigma-Aldrich) in DMEM at 37°C for 1 h. DMEM plus 10% FBS was added to double the volume, floating adipocytes were removed, and the digest was filtered through a 100-μm mesh that retained vessels of the stromal-particulate fraction. The filtrate was centrifuged at 800g for 5 min, and the SVF pellet was resuspended in DMEM containing 10% FBS and cultured for 2 days.
Isolation of primary MEFs was carried out as previously described (35 (link)). 3T3-L1 cells and MEFs were cultured in growth medium (DMEM plus 10% FBS) at subconfluence. For adipocyte differentiation, cells were grown to confluence and switched into differentiation medium I (growth medium plus 0.5 μmol/L IBMX, 1 μg/μL insulin, 0.25 μmol/L dexamethazone, 2 μmol/L rosiglitazone; Sigma-Aldrich) for 2 days. The culture medium was then changed to differentiation medium II (growth medium plus 2 μmol/L rosiglitazone), and the medium was changed every 2 days. To activate SHH signaling, MEFs were treated with 250 ng/mL SHH (R&D Systems) or 5.2 μmol/L purmorphamine (Calbiochem) in differentiation media from differentiation day 2 onward.
+ Open protocol
+ Expand
4

Adipocyte Differentiation Molecular Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Insulin, dexamethazone, BSA, MG-132, forskolin, lactacystin, E-64d, cycloheximide, anti-Flag antibody and a protease inhibitor cocktail were purchased from Sigma-Aldrich. IBMX and pioglitazone were from Wako Chemicals. ALLN and OAs were from Nacalai Tesque. Anti-PPARγ and anti-ubiquitin antibodies were from Santa Cruz Biotech. Anti-Plin1 and anti-Plin2 antibodies were from Progen. Anti-GFP and anti-actin antibodies were from Abcam and Chemicon, respectively.
+ Open protocol
+ Expand
5

Osteogenic Differentiation in Bioreactor

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to the experiment, the scaffolds were soaked and incubated in standard culture medium for 24 h. Next, samples were placed in bioreactor in a position, which ensured a permanent flow of the medium through the scaffolds. HBDCs were suspended in 0.5 L of culture medium (9 × 105 cells per sample) and put into the bioreactor. The cells were cultured in CO2 incubator, where the whole system was placed. After 1 week the medium was changed for a fresh medium enriched with 10 nM dexamethazone (Sigma, USA), 10 nM vitamin D3 (Sigma, USA) and 10 mM beta-glycerophosphate (Sigma, USA). From this time point 50 mL of medium was changed twice a week. The samples in bioreactor were cultured for 5 weeks.
+ Open protocol
+ Expand
6

Osteogenic Differentiation of Immortalized Human MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
An immortalised cell line of human bone marrow mesenchymal stem cells (MSCs) [26] was seeded at density of 3x10 4 cells/ml in standard MSC medium consisting of Dulbecco's Modified Eagle's Medium (DMEM), 10% FCS, 1 mM L-glutamine, 1% non-essential amino acids and 10% antibiotics, and incubated at 37°C in 5% CO 2 . For differentiation, confluent cells were treated with osteogenic medium (OS) consisting of standard MSC medium supplemented with 100 nm dexamethazone (Sigma-Aldrich, Gillingham, UK), 0.05 mM L-ascorbic acid 2 phosphate (Acros Organics, Geel, Belgium) and 10 mM beta glycerophosphate (βGP, Sigma-Aldrich) for 21 days with medium changes every 2 days. Parallel cultures maintained in standard MSC medium were used as untreated controls (C).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!